Cynomolgus non-human primate iPSC-derived ventricular-like cardiomyocytes provide a physiologically relevant in vitro system for translational cardiac research, enabling cross-species comparison between preclinical models and human biology. This platform supports mechanistic studies, cardiotoxicity screening, and drug development programs with improved translational confidence.
Ncyte® NHP-C vCardiomyocytes are functional, electrophysiologically active cardiomyocytes that form beating clusters within 72 hours and are compatible with assays such as MEA electrophysiology, imaging, impedance, contractility, and metabolic profiling. Their strong pharmacological responsiveness makes them suitable for cardiac safety testing and compound evaluation across discovery and preclinical research.